Diverse synthetic approaches towards C1′-branched acyclic nucleoside phosphonates
Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, t...
Saved in:
Published in | Organic & biomolecular chemistry Vol. 19; no. 32; pp. 6958 - 6963 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
CAMBRIDGE
Royal Soc Chemistry
28.08.2021
Royal Society of Chemistry |
Subjects | |
Online Access | Get full text |
ISSN | 1477-0520 1477-0539 1477-0539 |
DOI | 10.1039/d1ob00751c |
Cover
Loading…
Abstract | Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1′-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1′ position. These intermediates can be further vastly diversified into target C1′-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1′-branched ANPs is emphasized by their analogy with C1′-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity (
e.g.
antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research.
Five diverse synthetic methods leading to 6-chloropurine ANPs branched at C1′ position were developed/optimized. These key intermediates can be used for the synthesis of a library of C1′-branched ANPs for evaluation of their biological properties. |
---|---|
AbstractList | Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1'-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1' position. These intermediates can be further vastly diversified into target C1'-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1'-branched ANPs is emphasized by their analogy with C1'-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity (e.g. antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research.Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1'-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1' position. These intermediates can be further vastly diversified into target C1'-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1'-branched ANPs is emphasized by their analogy with C1'-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity (e.g. antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research. Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1′-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1′ position. These intermediates can be further vastly diversified into target C1′-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1′-branched ANPs is emphasized by their analogy with C1′-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity ( e.g. antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research. Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1 '-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1 ' position. These intermediates can be further vastly diversified into target C1 '-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1 '-branched ANPs is emphasized by their analogy with C1 '-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity (e.g. antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research. Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1′-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1′ position. These intermediates can be further vastly diversified into target C1′-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1′-branched ANPs is emphasized by their analogy with C1′-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity ( e.g. antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research. Five diverse synthetic methods leading to 6-chloropurine ANPs branched at C1′ position were developed/optimized. These key intermediates can be used for the synthesis of a library of C1′-branched ANPs for evaluation of their biological properties. |
Author | Janeba, Zlatko Dra ínský, Martin Kal ic, Filip |
AuthorAffiliation | Charles University Faculty of Science Department of Organic Chemistry Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences |
AuthorAffiliation_xml | – name: Department of Organic Chemistry – name: Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences – name: Faculty of Science – name: Charles University |
Author_xml | – sequence: 1 givenname: Filip surname: Kal ic fullname: Kal ic, Filip – sequence: 2 givenname: Martin surname: Dra ínský fullname: Dra ínský, Martin – sequence: 3 givenname: Zlatko surname: Janeba fullname: Janeba, Zlatko |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34032256$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks-KFDEQxoOsuLujF-9KgxdRWitJp9M5aq__YGEP6rlJ0tVMlp5kTNIuc_OZfCSfxOiMIywePBRVhN_3Uamqc3Lig0dCHlJ4QYGrlyMNBkAKau-QM9pIWYPg6uRYMzgl5yldA1Al2-YeOeUNcMZEe0Y-XrivGBNWaefzGrOzld5uY9B2janK4UbHMVU9_fHte22i9uV5rLTd2bmQfrEzhuRGrLbrkEp4nTHdJ3cnPSd8cMgr8vntm0_9-_ry6t2H_tVlbTmXudadVqCEslSMYqJGATeSMUul7mirqaTcgLSsoSOCQdBT21mGk5BsYoobviJP976l3y8LpjxsXLI4z9pjWNLARPlk05Uo6JNb6HVYoi_dFapljIMoI1mRxwdqMRsch210Gx13w59xFeD5HrhBE6ZkHXqLRwwAWsGlbFSpgBa6-3-6d1lnF3wfFp-L9NleamNIKeJ0lFEYfi19uKBXr38vvS8w3ILtwSxH7eZ_Sx7tJTHZo_XfO-I_AXZStYg |
CitedBy_id | crossref_primary_10_1002_cmdc_202300211 crossref_primary_10_1016_j_bioorg_2025_108240 crossref_primary_10_1016_j_ejmech_2024_116412 |
Cites_doi | 10.1038/nature17180 10.2147/DDDT.S261154 10.1080/15257770500268673 10.1021/cr5002035 10.1021/acs.jmedchem.6b01594 10.1135/cccc19961525 10.3851/IMP2012 10.1021/acscentsci.0c00489 10.1016/j.antiviral.2006.06.002 10.1128/CMR.00162-20 10.1016/S0040-4020(00)00422-1 10.1002/med.21283 10.1016/j.antiviral.2015.11.009 10.1016/j.antiviral.2020.104899 10.3390/molecules25184307 10.1021/jm0102755 10.1038/323464a0 10.1016/j.tetlet.2011.10.037 10.1038/nrd1877 10.1021/acs.orglett.6b00869 10.1039/c2ra20842c 10.1007/s40265-017-0754-9 10.2165/00003495-200363150-00006 10.1080/15257770500265315 10.1038/srep43395 10.2174/1381612033453668 10.1002/med.21296 |
ContentType | Journal Article |
Copyright | Copyright Royal Society of Chemistry 2021 |
Copyright_xml | – notice: Copyright Royal Society of Chemistry 2021 |
DBID | AAYXX CITATION 17B 1KM BLEPL DTL EGQ HGBXW CGR CUY CVF ECM EIF NPM 7QO 7T7 7TM 8FD C1K FR3 P64 7X8 |
DOI | 10.1039/d1ob00751c |
DatabaseName | CrossRef Web of Knowledge Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science Primary (SCIE, SSCI & AHCI) Web of Science - Science Citation Index Expanded - 2021 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Biotechnology Research Abstracts Technology Research Database Nucleic Acids Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef Web of Science Biotechnology Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1477-0539 |
EndPage | 6963 |
ExternalDocumentID | 34032256 000653774900001 10_1039_D1OB00751C d1ob00751c |
Genre | Journal Article |
GrantInformation_xml | – fundername: Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences; Czech Academy of Sciences grantid: RVO 61388963 – fundername: Ministry of Education, Youth and Sports (MSMT in Czech) in the program INTER-EXCELLENCE grantid: LTAUSA18086 |
GroupedDBID | - 0-7 0R 123 1TJ 29N 4.4 70 705 70J 7~J AAEMU AAGNR AAIWI AANOJ AAXPP ABASK ABDVN ABFLS ABGFH ABRYZ ACGFS ACIWK ACLDK ACNCT ACPRK ADMRA ADSRN AENEX AFRAH AFVBQ AGKEF AGRSR AGSTE AGSWI ALMA_UNASSIGNED_HOLDINGS ANUXI ASKNT AUDPV BLAPV BSQNT C6K CKLOX CS3 D0L DU5 DZ EBS ECGLT EE0 EF- F5P GNO HZ H~N IDZ J3I JG KC5 M4U N9A O9- OK1 P2P R7B R7C RCNCU RNS RPMJG RRA RRC RSCEA SKA SKF SLH TN5 TWZ UCJ VH6 VQA WH7 X YNT YZZ --- -DZ -~X 0R~ 70~ AAJAE AAMEH AAWGC AAXHV AAYXX ABEMK ABJNI ABPDG ABXOH AEFDR AENGV AESAV AETIL AFLYV AFOGI AFRDS AFRZK AGEGJ AHGCF AKMSF ALUYA APEMP CITATION GGIMP H13 HZ~ R56 RAOCF XSW 17B 1KM BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED GROUPED_WOS_WEB_OF_SCIENCE -JG CGR CUY CVF ECM EIF NPM 7QO 7T7 7TM 8FD C1K FR3 P64 7X8 |
ID | FETCH-LOGICAL-c337t-a8a90959c15d5f1b903b722c17a816a1713b07c241de0be0af68c2ef572f293b3 |
ISICitedReferencesCount | 4 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000653774900001 |
ISSN | 1477-0520 1477-0539 |
IngestDate | Fri Jul 11 05:15:41 EDT 2025 Mon Jun 30 12:02:10 EDT 2025 Wed Feb 19 02:09:10 EST 2025 Fri Aug 29 16:01:58 EDT 2025 Fri May 30 07:59:27 EDT 2025 Tue Jul 01 01:52:12 EDT 2025 Thu Apr 24 23:09:51 EDT 2025 Sun Apr 17 04:30:16 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 32 |
Keywords | MEDICINAL CHEMISTRY NUCLEOTIDE ANALOGS REMDESIVIR VIRUS PRODRUG GS-5734 EBOLA DERIVATIVES INHIBIT TENOFOVIR ALAFENAMIDE |
Language | English |
LinkModel | OpenURL |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-c337t-a8a90959c15d5f1b903b722c17a816a1713b07c241de0be0af68c2ef572f293b3 |
Notes | 10.1039/d1ob00751c Electronic supplementary information (ESI) available: General experimental information, standard procedures, spectral data, characterization and copies of spectra of prepared compounds. See DOI ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4391-8319 0000-0002-4495-0070 0000-0003-4654-679X |
PMID | 34032256 |
PQID | 2562230540 |
PQPubID | 2047497 |
PageCount | 6 |
ParticipantIDs | webofscience_primary_000653774900001 webofscience_primary_000653774900001CitationCount rsc_primary_d1ob00751c proquest_journals_2562230540 crossref_citationtrail_10_1039_D1OB00751C crossref_primary_10_1039_D1OB00751C proquest_miscellaneous_2532248224 pubmed_primary_34032256 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-08-28 |
PublicationDateYYYYMMDD | 2021-08-28 |
PublicationDate_xml | – month: 08 year: 2021 text: 2021-08-28 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | CAMBRIDGE |
PublicationPlace_xml | – name: CAMBRIDGE – name: England – name: Cambridge |
PublicationTitle | Organic & biomolecular chemistry |
PublicationTitleAbbrev | ORG BIOMOL CHEM |
PublicationTitleAlternate | Org Biomol Chem |
PublicationYear | 2021 |
Publisher | Royal Soc Chemistry Royal Society of Chemistry |
Publisher_xml | – name: Royal Soc Chemistry – name: Royal Society of Chemistry |
References | Charles (D1OB00751C/cit28) 1979; 94 De Clercq (D1OB00751C/cit1) 1986; 323 Chapman (D1OB00751C/cit9) 2003; 63 Warren (D1OB00751C/cit17) 2016; 531 Sun (D1OB00751C/cit22) 2016; 18 Wu (D1OB00751C/cit23b) 2005; 24 Holy (D1OB00751C/cit2) 2003; 9 Kundarapu (D1OB00751C/cit24) 2011; 52 Holý (D1OB00751C/cit3) 2006; 71 Ray (D1OB00751C/cit11) 2016; 125 Lo (D1OB00751C/cit16) 2017; 7 Hashemian (D1OB00751C/cit19) 2020; 14 De Clercq (D1OB00751C/cit5) 2013; 33 Baszczyňski (D1OB00751C/cit12) 2013; 33 Hocek (D1OB00751C/cit27) 1996; 61 Scott (D1OB00751C/cit10) 2017; 77 Siegel (D1OB00751C/cit14) 2017; 60 Cappellacci (D1OB00751C/cit13) 2002; 45 Jeffery (D1OB00751C/cit21) 2000; 56 Dejmek (D1OB00751C/cit25) 2012; 2 Slusarczyk (D1OB00751C/cit8) 2018; 26 Frydrych (D1OB00751C/cit26) 2020; 25 Eastman (D1OB00751C/cit18) 2020; 6 Wu (D1OB00751C/cit23a) 2005; 24 De Clercq (D1OB00751C/cit4) 2005; 4 Pertusat (D1OB00751C/cit6) 2012; 22 Konkolova (D1OB00751C/cit15) 2020; 182 Pradere (D1OB00751C/cit7) 2014; 114 Malin (D1OB00751C/cit20) 2020; 34 Jeffery, AL (WOS:000088199900003) 2000; 56 Konkolova, E (WOS:000576074300009) 2020; 182 Baszczynski, O (WOS:000325158000004) 2013; 33 Wu, MW (WOS:000234060900011) 2005; 24 Pradere, U (WOS:000342328500009) 2014; 114 DECLERCQ, E (WOS:A1986E225700061) 1986; 323 Sun, HL (WOS:000375891700080) 2016; 18 Lo, MK (WOS:000395416000001) 2017; 7 Pertusati (000653774900001.8) 2018; 26 Malin, JJ (WOS:000582927000003) 2021; 34 Holy, A (WOS:000240381200022) 2006; 71 MCKENNA, CE (WOS:A1979HM70100007) 1979 Hashemian, SM (WOS:000557425200001) 2020; 14 Holy, A (WOS:000186697900003) 2003; 9 Chapman, TM (WOS:000184678900006) 2003; 63 De Clercq, E (WOS:000325158000003) 2013; 33 Siegel, D (WOS:000396296100004) 2017; 60 Wu, MW (WOS:000234060900012) 2005; 24 Hocek, M (WOS:A1996VV80200011) 1996; 61 Warren, TK (WOS:000372064300055) 2016; 531 De Clercq, E (WOS:000233304600019) 2005; 4 Frydrych, J (WOS:000580384500001) 2020; 25 Eastman, RT (WOS:000537740300013) 2020; 6 Scott, LJ (WOS:000401714300007) 2017; 77 Cappellacci, L (WOS:000174506200005) 2002; 45 Dejmek, M (WOS:000306669300038) 2012; 2 Pertusati, Fabrizio (BCI:BCI201200571166) 2012; 22 Kundarapu, M (WOS:000297777600012) 2011; 52 Ray, AS (WOS:000369203900010) 2016; 125 |
References_xml | – issn: 2018 issue: 26 publication-title: Phosphoramidates and phosphonamidates (ProTides) with antiviral activity doi: Slusarczyk Serpi Pertusati – volume: 531 start-page: 381 year: 2016 ident: D1OB00751C/cit17 publication-title: Nature doi: 10.1038/nature17180 – volume: 14 start-page: 3215 year: 2020 ident: D1OB00751C/cit19 publication-title: Drug Des., Dev. Ther. doi: 10.2147/DDDT.S261154 – volume: 24 start-page: 1543 issue: 10–12 year: 2005 ident: D1OB00751C/cit23a publication-title: Nucleosides, Nucleotides Nucleic Acids doi: 10.1080/15257770500268673 – volume: 114 start-page: 9154 year: 2014 ident: D1OB00751C/cit7 publication-title: Chem. Rev. doi: 10.1021/cr5002035 – volume: 60 start-page: 1648 year: 2017 ident: D1OB00751C/cit14 publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.6b01594 – volume: 61 start-page: 1525 year: 1996 ident: D1OB00751C/cit27 publication-title: Collect. Czech. Chem. Commun. doi: 10.1135/cccc19961525 – volume: 22 start-page: 181 year: 2012 ident: D1OB00751C/cit6 publication-title: Antivir. Chem. Chemother. doi: 10.3851/IMP2012 – volume: 6 start-page: 672 issue: 5 year: 2020 ident: D1OB00751C/cit18 publication-title: ACS Cent. Sci. doi: 10.1021/acscentsci.0c00489 – volume: 71 start-page: 248 year: 2006 ident: D1OB00751C/cit3 publication-title: Antiviral Res. doi: 10.1016/j.antiviral.2006.06.002 – volume: 34 start-page: 1 year: 2020 ident: D1OB00751C/cit20 publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.00162-20 – volume: 56 start-page: 5077 year: 2000 ident: D1OB00751C/cit21 publication-title: Tetrahedron doi: 10.1016/S0040-4020(00)00422-1 – volume: 33 start-page: 1278 year: 2013 ident: D1OB00751C/cit5 publication-title: Med. Res. Rev. doi: 10.1002/med.21283 – volume: 125 start-page: 63 year: 2016 ident: D1OB00751C/cit11 publication-title: Antiviral Res. doi: 10.1016/j.antiviral.2015.11.009 – volume: 182 start-page: 104899 year: 2020 ident: D1OB00751C/cit15 publication-title: Antiviral Res. doi: 10.1016/j.antiviral.2020.104899 – volume: 25 start-page: 4307 year: 2020 ident: D1OB00751C/cit26 publication-title: Molecules doi: 10.3390/molecules25184307 – volume: 45 start-page: 1196 year: 2002 ident: D1OB00751C/cit13 publication-title: J. Med. Chem. doi: 10.1021/jm0102755 – volume: 323 start-page: 464 year: 1986 ident: D1OB00751C/cit1 publication-title: Nature doi: 10.1038/323464a0 – volume: 52 start-page: 6896 year: 2011 ident: D1OB00751C/cit24 publication-title: Tetrahedron Lett. doi: 10.1016/j.tetlet.2011.10.037 – volume: 4 start-page: 928 year: 2005 ident: D1OB00751C/cit4 publication-title: Nat. Rev. Drug Discovery doi: 10.1038/nrd1877 – volume: 94 start-page: 739 year: 1979 ident: D1OB00751C/cit28 publication-title: J. Chem. Soc., Chem. Commun. – volume: 26 volume-title: Phosphoramidates and phosphonamidates (ProTides) with antiviral activity year: 2018 ident: D1OB00751C/cit8 – volume: 18 start-page: 2260 year: 2016 ident: D1OB00751C/cit22 publication-title: Org. Lett. doi: 10.1021/acs.orglett.6b00869 – volume: 2 start-page: 6970 year: 2012 ident: D1OB00751C/cit25 publication-title: RSC Adv. doi: 10.1039/c2ra20842c – volume: 77 start-page: 1017 year: 2017 ident: D1OB00751C/cit10 publication-title: Drugs doi: 10.1007/s40265-017-0754-9 – volume: 63 start-page: 1597 year: 2003 ident: D1OB00751C/cit9 publication-title: Drugs doi: 10.2165/00003495-200363150-00006 – volume: 24 start-page: 1569 year: 2005 ident: D1OB00751C/cit23b publication-title: Nucleosides, Nucleotides Nucleic Acids doi: 10.1080/15257770500265315 – volume: 7 start-page: 43395 year: 2017 ident: D1OB00751C/cit16 publication-title: Sci. Rep. doi: 10.1038/srep43395 – volume: 9 start-page: 2567 year: 2003 ident: D1OB00751C/cit2 publication-title: Curr. Pharm. Des. doi: 10.2174/1381612033453668 – volume: 33 start-page: 1304 year: 2013 ident: D1OB00751C/cit12 publication-title: Med. Res. Rev. doi: 10.1002/med.21296 – volume: 25 start-page: ARTN 4307 year: 2020 ident: WOS:000580384500001 article-title: Efficient Synthesis of α-Branched Purine-Based Acyclic Nucleosides: Scopes and Limitations of the Method publication-title: MOLECULES doi: 10.3390/molecules25184307 – volume: 114 start-page: 9154 year: 2014 ident: WOS:000342328500009 article-title: Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs publication-title: CHEMICAL REVIEWS doi: 10.1021/cr5002035 – volume: 26 year: 2018 ident: 000653774900001.8 publication-title: Phosphoramidates and phosphonamidates (ProTides) with antiviral activity – start-page: 739 year: 1979 ident: WOS:A1979HM70100007 article-title: FUNCTIONAL SELECTIVITY IN PHOSPHONATE ESTER DEALKYLATION WITH BROMOTRIMETHYLSILANE publication-title: JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS – volume: 24 start-page: 1569 year: 2005 ident: WOS:000234060900012 article-title: Synthesis of 9-[1-(substituted)-2-(phosphonomethoxy)ethyl]adenine derivatives as possible antiviral agents publication-title: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS doi: 10.1080/15257770500265315 – volume: 24 start-page: 1543 year: 2005 ident: WOS:000234060900011 article-title: Synthesis of 9-[1-(substituted)-3-(phosphonomethoxy)propyl]adenine derivatives as possible antiviral agents publication-title: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS doi: 10.1080/15257770500268673 – volume: 7 start-page: ARTN 43395 year: 2017 ident: WOS:000395416000001 article-title: GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses publication-title: SCIENTIFIC REPORTS doi: 10.1038/srep43395 – volume: 45 start-page: 1196 year: 2002 ident: WOS:000174506200005 article-title: Ribose-modified nucleosides as ligands for adenosine receptors:: Synthesis, conformational analysis, and biological evaluation of 1′-C-methyl adenosine analogues publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm0102755 – volume: 56 start-page: 5077 year: 2000 ident: WOS:000088199900003 article-title: Synthesis of acyclic nucleoside and nucleotide analogues from amino acids: A convenient approach to a PMEA-PMPA hybrid publication-title: TETRAHEDRON – volume: 34 start-page: ARTN e00162-20 year: 2021 ident: WOS:000582927000003 article-title: Remdesivir against COVID-19 and Other Viral Diseases publication-title: CLINICAL MICROBIOLOGY REVIEWS doi: 10.1128/CMR.00162-20 – volume: 125 start-page: 63 year: 2016 ident: WOS:000369203900010 article-title: Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus publication-title: ANTIVIRAL RESEARCH doi: 10.1016/j.antiviral.2015.11.009 – volume: 33 start-page: 1304 year: 2013 ident: WOS:000325158000004 article-title: Medicinal Chemistry of Fluorinated Cyclic and Acyclic Nucleoside Phosphonates publication-title: MEDICINAL RESEARCH REVIEWS doi: 10.1002/med.21296 – volume: 71 start-page: 248 year: 2006 ident: WOS:000240381200022 article-title: Antiviral acyclic nucleoside phosphonates structure activity studies publication-title: ANTIVIRAL RESEARCH doi: 10.1016/j.antiviral.2006.06.002 – volume: 61 start-page: 1525 year: 1996 ident: WOS:A1996VV80200011 article-title: Synthesis and antiviral activity of acyclic nucleotide analogues derived from 6-(aminomethyl)purines and purine-6-carboxamidines publication-title: COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS – volume: 9 start-page: 2567 year: 2003 ident: WOS:000186697900003 article-title: Phosphonomethoxyalkyl analogs of nucleotides publication-title: CURRENT PHARMACEUTICAL DESIGN – volume: 77 start-page: 1017 year: 2017 ident: WOS:000401714300007 article-title: Tenofovir Alafenamide: A Review in Chronic Hepatitis B publication-title: DRUGS doi: 10.1007/s40265-017-0754-9 – volume: 6 start-page: 672 year: 2020 ident: WOS:000537740300013 article-title: Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 publication-title: ACS CENTRAL SCIENCE doi: 10.1021/acscentsci.0c00489 – volume: 323 start-page: 464 year: 1986 ident: WOS:A1986E225700061 article-title: A NOVEL SELECTIVE BROAD-SPECTRUM ANTI-DNA VIRUS AGENT publication-title: NATURE – volume: 14 start-page: 3215 year: 2020 ident: WOS:000557425200001 article-title: A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19 publication-title: DRUG DESIGN DEVELOPMENT AND THERAPY doi: 10.2147/DDDT.S261154 – volume: 33 start-page: 1278 year: 2013 ident: WOS:000325158000003 article-title: The Acyclic Nucleoside Phosphonates (ANPs): Antonin Holy's Legacy publication-title: MEDICINAL RESEARCH REVIEWS doi: 10.1002/med.21283 – volume: 531 start-page: 381 year: 2016 ident: WOS:000372064300055 article-title: Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys publication-title: NATURE doi: 10.1038/nature17180 – volume: 2 start-page: 6970 year: 2012 ident: WOS:000306669300038 article-title: One-pot build-up procedure for the synthesis of variously substituted purine derivatives publication-title: RSC ADVANCES doi: 10.1039/c2ra20842c – volume: 22 start-page: 181 year: 2012 ident: BCI:BCI201200571166 article-title: Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy publication-title: Antiviral Chemistry & Chemotherapy doi: 10.3851/IMP2012 – volume: 4 start-page: 928 year: 2005 ident: WOS:000233304600019 article-title: Acyclic nucleoside phosphonates: A key class of antiviral drugs publication-title: NATURE REVIEWS DRUG DISCOVERY doi: 10.1038/nrd1877 – volume: 60 start-page: 1648 year: 2017 ident: WOS:000396296100004 article-title: Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo(2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/acs.jmedchem.6b01594 – volume: 182 start-page: ARTN 104899 year: 2020 ident: WOS:000576074300009 article-title: Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses publication-title: ANTIVIRAL RESEARCH doi: 10.1016/j.antiviral.2020.104899 – volume: 18 start-page: 2260 year: 2016 ident: WOS:000375891700080 article-title: Asymmetric Hydrogenation of α-Purine Nucleobase-Substituted Acrylates with Rhodium Diphosphine Complexes: Access to Tenofovir Analogues publication-title: ORGANIC LETTERS doi: 10.1021/acs.orglett.6b00869 – volume: 52 start-page: 6896 year: 2011 ident: WOS:000297777600012 article-title: Synthesis of new acyclic nucleoside phosphonates (ANPs) substituted on the 1′ and/or 2′ positions publication-title: TETRAHEDRON LETTERS doi: 10.1016/j.tetlet.2011.10.037 – volume: 63 start-page: 1597 year: 2003 ident: WOS:000184678900006 article-title: Tenofovir disoproxil fumarate publication-title: DRUGS |
SSID | ssj0019764 |
Score | 2.3671558 |
Snippet | Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to... |
Source | Web of Science |
SourceID | proquest pubmed webofscience crossref rsc |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 6958 |
SubjectTerms | Antineoplastic Agents - chemical synthesis Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Antiviral Agents - chemical synthesis Antiviral Agents - chemistry Antiviral Agents - pharmacology Bases (nucleic acids) Biological activity Chemistry Chemistry, Organic Cyclic nucleotides Intermediates Molecular Structure Nucleosides Nucleosides - chemical synthesis Nucleosides - chemistry Nucleosides - pharmacology Nucleotides Organophosphonates - chemical synthesis Organophosphonates - chemistry Organophosphonates - pharmacology Phosphonates Physical Sciences Science & Technology |
Title | Diverse synthetic approaches towards C1′-branched acyclic nucleoside phosphonates |
URI | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000653774900001 https://www.ncbi.nlm.nih.gov/pubmed/34032256 https://www.proquest.com/docview/2562230540 https://www.proquest.com/docview/2532248224 |
Volume | 19 |
WOS | 000653774900001 |
WOSCitedRecordID | wos000653774900001 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaW7QEuiFdpoKAgekGrQGxn8zh2s60K4nFgK1VcFtuJValVUu1mD3DiN_GT-CXMOI4T1EUqXFaR492sPF_Gn-2Zbwg5KDQtVKp1MKWKBZFQPBBhyQKmpNQ6ylQq8ET3w8f45DR6dzY9G42-DqKWNo18rb5vzSv5H6tCG9gVs2T_wbLuR6EBrsG-8AkWhs8b2XhugipKlB0AHmekV61EuBFuwIDY9SSnNqBhxgKJZTTOgWMK9U2hvHWFcsY1luycXJ3XawxUR_I5pKxttqYyGMFk_a6e7kR1teKc00YBD1Mx_Rh3aRxHXomJOY-fV-sLvJjNbZZQJ_ttcv2rUhoi--VSNBf1cDeCme1VNnSgUZIEGFvTzi_Dtla0yHndbIAuu8XZ-tA4a8Xc7XwcZ60HvObrQ45SqQWtJfIeqvoZzcUZ9jdvkR0GCwk2JjuHR4u3791JE9AxE3nQ_e9OwpZnb_pv_0larq1EgJes1mordTE0ZXGP3LXrC_-wBct9MiqrB-R23pnqIflsQeM70Pg9aHwLGj-nv378dHDxLVz8Hi7-EC6PyOnx0SI_CWxljUBxnjSBSEWGG8CKTouppjILuYTBUTQRKY0FTSiXYaKA3RVlKMtQ6DhVrNTThGngh5LvknFVV-Ue8YusQNE0IQQvUehS6ELxVCZKhzJUKfPIq27olsrKzmP1k8ulCX_g2XJOP83MMOceeen6XrViK1t77XcWWNqXcb0E5g5EF9cfHnnhbsPQ4vkXILjeYB-YvSIMm_bI49Zy7jE8CnFqiz2yC6Z0zT0EPHIwtK7rYUg8h0VUZg7KPEJv0i23I4HCE82Tvz3zKbnTv2P7ZNysNuUz4MCNfG5h_BvnXrEy |
linkProvider | Royal Society of Chemistry |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diverse+synthetic+approaches+towards+C1%E2%80%B2-branched+acyclic+nucleoside+phosphonates&rft.jtitle=Organic+%26+biomolecular+chemistry&rft.au=Kal+ic%2C+Filip&rft.au=Dra+%C3%ADnsk%C3%BD%2C+Martin&rft.au=Janeba%2C+Zlatko&rft.date=2021-08-28&rft.issn=1477-0520&rft.eissn=1477-0539&rft.volume=19&rft.issue=32&rft.spage=6958&rft.epage=6963&rft_id=info:doi/10.1039%2Fd1ob00751c&rft.externalDocID=d1ob00751c |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-0520&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-0520&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-0520&client=summon |